Concepedia
Statistics
Publications
61
Citations
8.1K
H-Index
42
Active since
2012
Affiliations
Genome British Columbia(Current)
Mayo Clinic in Arizona
Johns Hopkins University
Mayo Clinic
Thomas Jefferson University
Nicholas Erho is an author at Genome British Columbia specializing in oncology, medicine, and prostate cancer.
Publications per year
2012–2019
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
Roland Seiler, H.A.D.M. Ashab, Nicholas Erho et al. · European Urology · 2017 · 792 citations
Medicine, Oncology, Urology +13
The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex
John R. Prensner, Matthew K. Iyer, Anirban Sahu et al. · Nature Genetics · 2013 · 683 citations · Full text
Medicine, Genetics, Molecular Biology +10
Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy
Nicholas Erho, Anamaria Crisan, Ismael A. Vergara et al. · PLoS ONE · 2013 · 665 citations · Full text
Medicine, Oncology, Urology +17
The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer
Dimple Chakravarty, Andrea Sboner, Sujit S. Nair et al. · Nature Communications · 2014 · 630 citations · Full text
Medicine, Molecular Biology, Oncology +17
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
Emilie Lalonde, Adrian Ishkanian, Jenna Sykes et al. · The Lancet Oncology · 2014 · 351 citations · Full text
1–5 of 61